Cytosorbents (CTSO) EBT Growth (5y) (2015 - 2026)

Cytosorbents (CTSO) EBT Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn
2 Stryker 129.08 Bn 126.21 Bn 3.81 Bn
3 Medtronic 108.57 Bn 99.35 Bn 6.41 Bn
4 Boston Scientific 68.52 Bn 67.07 Bn 3.61 Bn
5 Edwards Lifesciences 48.35 Bn 44.68 Bn 1.29 Bn
6 Dexcom 28.35 Bn 27.24 Bn 750.30 Mn
7 GE HealthCare Technologies 28.17 Bn 25.88 Bn 1.98 Bn
8 Smith & Nephew 26.91 Bn 26.33 Bn -
9 Koninklijke Philips 24.37 Bn 21.25 Bn 2.07 Bn
10 Cytosorbents 22.51 Mn 17.71 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.51%
Dec 31, 2025 -24.95%
Sep 30, 2025 -33.58%
Jun 30, 2025 -54.47%
Mar 31, 2025 15.60%
Dec 31, 2024 20.01%
Sep 30, 2024 16.66%
Jun 30, 2024 -3.90%
Mar 31, 2024 -4.51%
Dec 31, 2023 -2.90%
Sep 30, 2023 -25.05%
Jun 30, 2023 -2.55%
Mar 31, 2023 -19.68%
Dec 31, 2022 13.43%
Sep 30, 2022 -42.81%
Jun 30, 2022 -44.37%
Mar 31, 2022 -42.52%
Dec 31, 2021 -13.96%
Sep 30, 2021 -23.97%
Jun 30, 2021 -9.25%